Journal
CRITICAL CARE
Volume 25, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s13054-021-03710-6
Keywords
Coronavirus disease 2019; COVID-19; Acute respiratory failure; ICU; Invasive ventilation; Driving pressure; Delta P; Mechanical power of ventilation; Mechanical power; Mortality
Categories
Funding
- Amsterdam University Medical Centers, location 'AMC'
Ask authors/readers for more resources
This study on invasively ventilated COVID-19 patients with acute respiratory failure found that mechanical power (MP) was independently associated with 28-day mortality, while driving pressure (ΔP) was not. Increasing quartiles of MP, stratified on comparable levels of ΔP, were associated with higher risks of 28-day mortality. These findings suggest that efforts to limit both ΔP and MP could lead to better outcomes for these patients.
Background: The intensity of ventilation, reflected by driving pressure (Delta P) and mechanical power (MP), has an association with outcome in invasively ventilated patients with or without acute respiratory distress syndrome (ARDS). It is uncertain if a similar association exists in coronavirus disease 2019 (COVID-19) patients with acute respiratory failure. Methods: We aimed to investigate the impact of intensity of ventilation on patient outcome. The PRoVENT-COVID study is a national multicenter observational study in COVID-19 patients receiving invasive ventilation. Ventilator parameters were collected a fixed time points on the first calendar day of invasive ventilation. Mean dynamic Delta P and MP were calculated for individual patients at time points without evidence of spontaneous breathing. A Cox proportional hazard model, and a double stratification analysis adjusted for confounders were used to estimate the independent associations of Delta P and MP with outcome. The primary endpoint was 28-day mortality. Results: In 825 patients included in this analysis, 28-day mortality was 27.5%. Delta P was not independently associated with mortality (HR 1.02 [95% confidence interval 0.88-1.18]; P = 0.750). MP, however, was independently associated with 28-day mortality (HR 1.17 [95% CI 1.01-1.36]; P = 0.031), and increasing quartiles of MP, stratified on comparable levels of Delta P, had higher risks of 28-day mortality (HR 1.15 [95% CI 1.01-1.30]; P = 0.028). Conclusions: In this cohort of critically ill invasively ventilated COVID-19 patients with acute respiratory failure, we show an independent association of MP, but not Delta P with 28-day mortality. MP could serve as one prognostic biomarker in addition to Delta P in these patients. Efforts aiming at limiting both Delta P and MP could translate in a better outcome.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available